Hypoglycémiant And NotM. Cotterchio
List of bibliographic references
Number of relevant bibliographic references: 8.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000D06 | Andreas Liebl [Allemagne] ; Vinay Prusty [Suisse] ; Paul Valensi [France] ; Ryuzo Kawamori [Japon] ; Jens Sandahl Christiansen [Danemark] ; Andrew J. Palmer [Australie] ; Per Balschmidt [Danemark] ; Robert Ligthelm [Pays-Bas] ; Viswanathan Mohan [Inde] | Ten Years of Experience with Biphasic Insulin Aspart 30: From Drug Development to the Latest Clinical Findings |
| 000D89 | Michaela Diamant [Pays-Bas] ; Luc Van Gaal [Belgique] ; Stephen Stranks [Australie] ; Bruno Guerci [France] ; Leigh Macconell [États-Unis] ; Harry Haber [États-Unis] ; Jamie Scism-Bacon [États-Unis] ; Michael Trautmann [États-Unis] | Safety and Efficacy of Once-Weekly Exenatide Compared With Insulin Glargine Titrated to Target in Patients With Type 2 Diabetes Over 84 Weeks |
| 001970 | Bernard Zinman [Canada] ; Greg Fulcher [Australie] ; Paturi V. Rao [Inde] ; Nihal Thomas [Inde] ; Lars A. Endahl [Danemark] ; Thue Johansen [États-Unis] ; Rebecka Lindh [États-Unis] ; Andrew Lewin [États-Unis] ; Julio Rosenstock [États-Unis] ; Michel Pinget [France] ; Chantal Mathieu [Belgique] | Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial |
| 002A27 | M. Marre [France] ; J. Shaw [Australie] ; M. Br Ndle [Suisse] ; W. M. W. Bebakar [Malaisie] ; N. A. Kamaruddin [Malaisie] ; J. Strand [Finlande] ; M. Zdravkovic [Danemark] ; T. D. Le Thi [Danemark] ; S. Colagiuri [Australie] | Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU) |
| 004633 | Serge Halimi [France] ; Philip Raskin [États-Unis] ; Andreas Liebl [Allemagne] ; Ryuzo Kawamori [Japon] ; Greg Fulcher [Australie] ; GAO YAN [République populaire de Chine] | Efficacy of biphasic insulin aspart in patients with type 2 diabetes |
| 004B04 | Philip Home [Royaume-Uni] ; Paul Bartley [Australie] ; David Russell-Jones [Royaume-Uni] ; Hélène Hanaire-Broutin [France] ; Jan-Evert Heeg [Pays-Bas] ; Pascale Abrams [Belgique] ; Mona Landin-Olsson [Suède] ; Birgitte Hylleberg [Danemark] ; Hanne Lang [Danemark] ; Eberhard Draeger [Danemark] | Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes a randomized clinical trial |
| 004D28 | John Chalmers [Australie] | Etude ADVANCE: objectifs, protocole et état actuel |
| 005C54 | Pascal Bousquet [France] ; Monique Dontenwill [France] ; Hugues Greney [France] ; Josiane Feldman [France] | Imidazoline receptors in cardiovascular and metabolic diseases |
| This area was generated with Dilib version V0.6.33. |  |